Literature DB >> 19811916

Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.

Jennifer M Sealy1, Anh P Truong, Luke Tso, Gary D Probst, Jose Aquino, Roy K Hom, Barbara M Jagodzinska, Darren Dressen, David W G Wone, Louis Brogley, Varghese John, Jay S Tung, Michael A Pleiss, John A Tucker, Andrei W Konradi, Michael S Dappen, Gergely Toth, Hu Pan, Lany Ruslim, Jim Miller, Michael P Bova, Sukanto Sinha, Kevin P Quinn, John-Michael Sauer.   

Abstract

Using structure-guided design, hydroxyethylamine BACE-1 inhibitors were optimized to nanomolar Abeta cellular inhibition with selectivity against cathepsin-D. X-ray crystallography illuminated the S1' residues critical to this effort, which culminated in compounds 56 and 57 that exhibited potency and selectivity but poor permeability and high P-gp efflux.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811916     DOI: 10.1016/j.bmcl.2009.09.061

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Performance evaluation of molecular docking and free energy calculations protocols using the D3R Grand Challenge 4 dataset.

Authors:  Eddy Elisée; Vytautas Gapsys; Nawel Mele; Ludovic Chaput; Edithe Selwa; Bert L de Groot; Bogdan I Iorga
Journal:  J Comput Aided Mol Des       Date:  2019-11-01       Impact factor: 3.686

2.  Design and Synthesis of Novel Arylketo-containing P1-P3 Linked Macro-cyclic BACE-1 Inhibitors.

Authors:  Veronica Sandgren; Oscar Belda; Ingemar Kvarnström; Jimmy Lindberg; Bertil Samuelsson; Anders Dahlgren
Journal:  Open Med Chem J       Date:  2015-03-31

3.  β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment.

Authors:  Jun Cai; Xiaoping Qi; Norbert Kociok; Sergej Skosyrski; Alonso Emilio; Qing Ruan; Song Han; Li Liu; Zhijuan Chen; Catherine Bowes Rickman; Todd Golde; Maria B Grant; Paul Saftig; Lutgarde Serneels; Bart de Strooper; Antonia M Joussen; Michael E Boulton
Journal:  EMBO Mol Med       Date:  2012-08-20       Impact factor: 12.137

4.  Strong nonadditivity as a key structure-activity relationship feature: distinguishing structural changes from assay artifacts.

Authors:  Christian Kramer; Julian E Fuchs; Klaus R Liedl
Journal:  J Chem Inf Model       Date:  2015-03-11       Impact factor: 4.956

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.